Paul Choi

Stock Analyst at Goldman Sachs

(3.46)
# 861
Out of 4,893 analysts
108
Total ratings
52.11%
Success rate
4.03%
Average return

Stocks Rated by Paul Choi

Amarin Corporation
Jun 25, 2025
Maintains: Sell
Price Target: $7$12
Current: $17.15
Upside: -30.03%
UroGen Pharma
May 22, 2025
Maintains: Neutral
Price Target: $16$3
Current: $14.08
Upside: -78.69%
Gossamer Bio
May 16, 2025
Maintains: Buy
Price Target: $7$8
Current: $1.35
Upside: +492.59%
Phathom Pharmaceuticals
May 2, 2025
Maintains: Neutral
Price Target: $10$5
Current: $9.31
Upside: -46.29%
Arvinas
May 2, 2025
Maintains: Neutral
Price Target: $12$8
Current: $8.00
Upside: -
Xenon Pharmaceuticals
Apr 17, 2025
Maintains: Buy
Price Target: $60$52
Current: $32.70
Upside: +59.02%
Vir Biotechnology
Apr 17, 2025
Maintains: Buy
Price Target: $28$21
Current: $6.14
Upside: +242.02%
REGENXBIO
Apr 17, 2025
Maintains: Neutral
Price Target: $14$12
Current: $8.97
Upside: +33.85%
Esperion Therapeutics
Apr 17, 2025
Maintains: Neutral
Price Target: $4$3
Current: $1.21
Upside: +147.93%
Dynavax Technologies
Apr 17, 2025
Maintains: Sell
Price Target: $12$10
Current: $10.98
Upside: -8.93%
Maintains: Buy
Price Target: $200$225
Current: $175.09
Upside: +28.51%
Initiates: Buy
Price Target: $143
Current: $84.93
Upside: +68.37%
Maintains: Sell
Price Target: $32$42
Current: $49.11
Upside: -14.48%
Downgrades: Neutral
Price Target: $85$60
Current: $36.72
Upside: +63.40%
Maintains: Neutral
Price Target: $17$19
Current: $16.11
Upside: +17.96%
Maintains: Buy
Price Target: $22$32
Current: $28.72
Upside: +11.42%
Maintains: Buy
Price Target: $29$50
Current: $46.27
Upside: +8.06%
Maintains: Buy
Price Target: $21$19
Current: $5.27
Upside: +260.24%
Maintains: Sell
Price Target: $400$50
Current: $6.63
Upside: +654.15%
Maintains: Buy
Price Target: $43$25
Current: $1.26
Upside: +1,884.13%
Maintains: Buy
Price Target: $151$170
Current: $14.70
Upside: +1,056.46%
Maintains: Sell
Price Target: $9$8
Current: $3.58
Upside: +123.46%
Assumes: Buy
Price Target: $33
Current: $30.00
Upside: +10.02%
Downgrades: Neutral
Price Target: $135
Current: $134.46
Upside: +0.40%
Upgrades: Neutral
Price Target: $270$300
Current: $23.25
Upside: +1,190.32%